The Hydrocephalus Association (HA) is grateful for the continued support of our broad base of engaged community members that include patients living with hydrocephalus, family and friends of those affected, medical professionals that care for our community, and industry partners that provide the medical technology that allows our patients to live full lives.
HA discloses the financial support it receives from all sponsors. The companies below have provided funding for a variety of programmatic efforts including: an innovative research program, support services for patients and their loved ones, educational programs, our biennial conference, and awareness raising activities. We gratefully acknowledge their support.
2018 Corporate Sponsors
The following disclosure information includes the total amount of support received from each corporate sponsor. In 2018, 3.1% of HA’s overall revenue came from medical device companies. The specific amounts are:
| Integra | $59,400 | |
| Medtronic | $50,175 | |
| Aesculap Neurosurgery | $10,000 | |
| Alycone Lifesciences, Inc. (Anuncia Inc) | $5,000 | |
| Longeviti | $2,650 | |
| Allergan Foundation | $2,500 | |
| Karl Storz | $2,500 | |
| Neurallys | $1,850 | |
| NeuroDx | $1,600 | |
| Synaptive Medical | $1,600 | |
| Likvor | $1,580 | |
| Sophysa (Tragus Surgical) | $1,500 |
